Terri B. Sebree, President at Zynerba Pharmaceuticals, Inc. (ZYNE), sold 12,401 shares at $1.33 ($16K) on 2023-09-13, disclosed to the SEC on 2023-09-14.
Open-market sale of $16k ZYNE by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ZYNE | BUY | 2018-08-07 | $22K | — | Filing → |